iShares U.S. Pharmaceuticals ETF Rating $67.13 -0.23 (-0.34%) As of 07/18/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.66Holdings in IHE have an aggregate rating of Moderate Buy based on 342 analyst ratings issued in the past year covering 36 companies (99.9% of the portfolio).IHE Aggregate Price Target$67.13High Prediction$67.13Average Prediction$67.13Low Prediction$67.13Holdings in IHE have an aggregate price target of $67.13 and a range of $67.13 to $67.13 covering 36 companies (99.9% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 36 IHE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings22.71%JNJJohnson & Johnson$163.65+0.4%4.769 of 5 stars2.57$172.87 5.6%21Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastOptions VolumeAnalyst Revision21.84%LLYEli Lilly and Company$771.78+1.3%4.9772 of 5 stars2.75$1,012.56 31.2%20Trending News4.82%RPRXRoyalty Pharma$35.59+0.3%4.9698 of 5 stars3.25$48.33 35.8%4News CoveragePositive NewsDividend Announcement4.71%VTRSViatris$8.88-4.2%3.009 of 5 stars1.80$10.40 17.1%5Trending News4.69%PFEPfizer$24.46-0.5%4.9688 of 5 stars2.45$28.55 16.7%22Trending News4.65%MRKMerck & Co., Inc.$79.97-1.9%4.9954 of 5 stars2.43$108.69 35.9%21Positive News4.33%ZTSZoetis$148.61-0.9%4.9577 of 5 stars2.70$204.63 37.7%10Trending NewsAnalyst DowngradeAnalyst Revision4.30%BMYBristol Myers Squibb$47.40-1.4%4.8659 of 5 stars2.32$57.69 21.7%22Trending NewsAnalyst Revision3.62%ELANElanco Animal Health$14.78-1.2%2.0442 of 5 stars2.88$16.00 8.3%8Analyst UpgradeAnalyst Revision3.35%JAZZJazz Pharmaceuticals$112.87-1.7%4.8467 of 5 stars2.93$181.71 61.0%14Analyst Forecast3.33%CORTCorcept Therapeutics$70.86-3.1%4.8222 of 5 stars3.00$138.25 95.1%52.13%AXSMAxsome Therapeutics$111.70-0.5%4.7162 of 5 stars3.06$172.33 54.3%16Analyst Revision1.96%PBHPrestige Consumer Healthcare$75.70+0.8%4.0045 of 5 stars2.50$93.33 23.3%6News CoveragePositive NewsAnalyst Revision1.85%PRGOPerrigo$26.95-0.7%4.6287 of 5 stars2.25$33.00 22.4%4News CoveragePositive News1.31%OGNOrganon & Co.$9.46-1.9%4.8533 of 5 stars2.50$18.00 90.3%6Trending News1.09%LGNDLigand Pharmaceuticals$139.10+1.1%3.6541 of 5 stars3.00$147.17 5.8%6High Trading Volume0.89%SUPNSupernus Pharmaceuticals$32.34-3.7%2.5716 of 5 stars2.33$36.00 11.3%3Positive News0.77%TARSTarsus Pharmaceuticals$43.25+4.5%1.4918 of 5 stars3.00$66.67 54.1%7News CoverageAnalyst RevisionGap Up0.62%AMRXAmneal Pharmaceuticals$7.97-3.3%3.1904 of 5 stars3.00$11.60 45.5%5News Coverage0.61%HRMYHarmony Biosciences$35.20-3.4%4.8347 of 5 stars3.00$51.33 45.8%9Positive News0.60%OCULOcular Therapeutix$11.33-0.4%3.6517 of 5 stars3.00$17.33 53.0%60.55%ANIPANI Pharmaceuticals$66.30-2.6%3.9545 of 5 stars3.00$78.88 19.0%90.53%PCRXPacira BioSciences$21.59-3.1%3.111 of 5 stars2.33$26.44 22.5%9Analyst Revision0.53%INVAInnoviva$19.57-1.6%4.1711 of 5 stars3.00$40.33 106.1%3Analyst Revision0.49%COLLCollegium Pharmaceutical$31.20-3.3%4.4138 of 5 stars2.75$43.75 40.2%4Positive News0.48%HROWHarrow$35.89-0.7%2.4175 of 5 stars3.00$63.83 77.9%7Trending NewsAnalyst Revision0.45%EWTXEdgewise Therapeutics$13.54-1.4%1.2193 of 5 stars2.80$40.00 195.4%100.43%AMPHAmphastar Pharmaceuticals$20.62-5.0%4.2907 of 5 stars2.25$32.33 56.8%40.40%WVEWAVE Life Sciences$8.34+4.1%4.5704 of 5 stars2.92$20.15 141.7%13Analyst Forecast0.40%ELVNEnliven Therapeutics$22.66-2.9%2.7299 of 5 stars3.00$41.20 81.8%5News Coverage0.29%LQDALiquidia Technologies$14.54-0.4%3.2608 of 5 stars3.00$26.89 84.9%9Insider Trade0.27%ARVNArvinas$7.35-5.3%3.8933 of 5 stars2.55$20.29 176.0%220.26%NUVBNuvation Bio$2.31+3.1%2.853 of 5 stars3.20$7.17 210.2%50.24%MNMDMind Medicine (MindMed)$8.882.103 of 5 stars3.27$25.50 187.2%110.23%EOLSEvolus$9.20-1.5%3.928 of 5 stars3.00$23.75 158.2%50.19%TBPHTheravance Biopharma$11.25-3.2%1.5819 of 5 stars2.67$16.60 47.6%6News CoverageInsider Trade This page (NYSEARCA:IHE) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IHE Stock Alerts